Published in Lancet on October 01, 1977
Metoprolol metabolism and debrisoquine oxidation polymorphism--population and family studies. Br J Clin Pharmacol (1985) 1.64
Comparison of two long-acting preparations of metoprolol with conventional metoprolol and atenolol in healthy men during chronic dosing. Br J Clin Pharmacol (1982) 1.55
Molecular genetics of CYP2D6: clinical relevance with focus on psychotropic drugs. Br J Clin Pharmacol (2002) 1.52
Defective metabolism of metoprolol in poor hydroxylators of debrisoquine. Br J Clin Pharmacol (1982) 1.52
Evidence for an enzymatic defect in the 4-hydroxylation of debrisoquine by human liver. Br J Clin Pharmacol (1981) 1.47
Polymorphic drug oxidation: pharmacokinetic basis and comparison of experimental indices. Br J Clin Pharmacol (1986) 1.29
Polymorphic metabolism of beta-adrenoceptor antagonists. Br J Clin Pharmacol (1984) 1.08
Testing for bimodality in frequency distributions of data suggesting polymorphisms of drug metabolism--hypothesis testing. Br J Clin Pharmacol (1989) 0.99
Disposition and metabolism of codeine after single and chronic doses in one poor and seven extensive metabolisers. Br J Clin Pharmacol (1991) 0.97
Assay and characterisation of debrisoquine 4-hydroxylase activity of microsomal fractions of human liver. Br J Clin Pharmacol (1982) 0.91
Accumulation of debrisoquine by platelets in vivo: a model of events at the peripheral adrenergic neurone. Br J Clin Pharmacol (1980) 0.88
The influence of cytochrome P450 pharmacogenetics on disposition of common antidepressant and antipsychotic medications. Clin Biochem Rev (2006) 0.86
Influence of amino acid residue 374 of cytochrome P-450 2D6 (CYP2D6) on the regio- and enantio-selective metabolism of metoprolol. Biochem J (1996) 0.84
Debrisoquine oxidation in a Finnish population: the effect of oral contraceptives on the metabolic ratio. Br J Clin Pharmacol (1988) 0.78
Enantioselectivity of 4-hydroxylation in extensive and poor metabolizers of debrisoquine. Br J Clin Pharmacol (1988) 0.78
Research priorities in pharmacokinetics. Br J Clin Pharmacol (2012) 0.76
The role of cytochrome P4502D6 in the metabolism of paroxetine by human liver microsomes. Br J Clin Pharmacol (1992) 0.75
Personalized Drug Dosage - Closing the Loop. Pharm Res (2016) 0.75
Cloning in single-stranded bacteriophage as an aid to rapid DNA sequencing. J Mol Biol (1980) 61.16
Sequence and organization of the human mitochondrial genome. Nature (1981) 57.39
Size and charge isomer separation and estimation of molecular weights of proteins by disc gel electrophoresis. Arch Biochem Biophys (1968) 15.05
DNA sequence analysis by primed synthesis. Methods Enzymol (1980) 4.75
Biochemical basis of obligate autotrophy in blue-green algae and thiobacilli. J Bacteriol (1967) 4.63
The oncogenic cysteine-rich LIM domain protein rbtn2 is essential for erythroid development. Cell (1994) 4.58
Time for a review of admission to medical school? Lancet (1995) 4.56
A dust-obscured massive maximum-starburst galaxy at a redshift of 6.34. Nature (2013) 4.43
Nitrogen chlorosis in blue-green algae. Arch Mikrobiol (1969) 4.18
Restoration of vision after transplantation of photoreceptors. Nature (2012) 3.91
A method for sequencing restriction fragments with dideoxynucleoside triphosphates. Nucleic Acids Res (1978) 3.90
Different pattern of codon recognition by mammalian mitochondrial tRNAs. Proc Natl Acad Sci U S A (1980) 3.74
Assessment of inactivated influenza-A vaccine after three outbreaks of influenza A at Christ's Hospital. Lancet (1979) 3.55
A potent synthetic peptide inhibitor of the cAMP-dependent protein kinase. J Biol Chem (1986) 3.49
Inhibition of antipyrine metabolism by beta-adrenoceptor antagonists. Br J Clin Pharmacol (1981) 3.07
Altered nociception, analgesia and aggression in mice lacking the receptor for substance P. Nature (1998) 2.90
MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine. Cell (1996) 2.87
Acetate assimilation by Nitrobacter agilis in relation to its "obligate autotrophy". J Bacteriol (1968) 2.74
Warm-coding deficits and aberrant inflammatory pain in mice lacking P2X3 receptors. Nature (2000) 2.73
Oxidation phenotype--a major determinant of metoprolol metabolism and response. N Engl J Med (1982) 2.72
Two genetically separable steps in the differentiation of thymic epithelium. Science (1996) 2.66
Homologous recombination between defective neo genes in mouse 3T6 cells. Cold Spring Harb Symp Quant Biol (1984) 2.65
Antibiotic prescribing for sinusitis? Br Dent J (2000) 2.55
Saphenous vein puncture for blood sampling of the mouse, rat, hamster, gerbil, guinea pig, ferret and mink. Lab Anim (1998) 2.51
The use of exonuclease III for preparing single stranded DNA for use as a template in the chain terminator sequencing method. Nucleic Acids Res (1979) 2.51
Endoglin, an ancillary TGFbeta receptor, is required for extraembryonic angiogenesis and plays a key role in heart development. Dev Biol (2000) 2.50
Determination of debrisoquine and its 4-hydroxy metabolite in biological fluids by gas chromatography with flame-ionization and nitrogen-selective detection. J Chromatogr (1977) 2.43
Self-poisoning with drugs: a worsening situation. Br Med J (1972) 2.43
Amiodarone pharmacokinetics. Am Heart J (1983) 2.42
Metformin kinetics in healthy subjects and in patients with diabetes mellitus. Br J Clin Pharmacol (1981) 2.38
A virus from epidemic vomiting disease. Br Med J (1972) 2.26
Submillimetre galaxies reside in dark matter haloes with masses greater than 3 × 10(11) solar masses. Nature (2011) 2.21
A new redox cofactor in eukaryotic enzymes: 6-hydroxydopa at the active site of bovine serum amine oxidase. Science (1990) 2.16
Ligand-gated ion channel subunit partnerships: GABAA receptor alpha6 subunit gene inactivation inhibits delta subunit expression. J Neurosci (1997) 2.08
Inhibition of oxidative drug metabolism by beta-adrenoceptor antagonists in related to their lipid solubility. Br J Clin Pharmacol (1981) 2.08
A crosslinked cofactor in lysyl oxidase: redox function for amino acid side chains. Science (1996) 2.06
CpG ODN-induced matrix metalloproteinase-13 expression is mediated via activation of the ERK and NF-κB signalling pathways in odontoblast cells. Int Endod J (2013) 2.03
Influenza A and meningococcal disease. Lancet (1991) 2.00
Impact of a short course in pharmacotherapy for undergraduate medical students: an international randomised controlled study. Lancet (1995) 1.97
Influenza at Christ's Hospital: March, 1974. Lancet (1976) 1.96
Clinical evaluation of Dinamap 845 automated blood pressure recorder. Br Heart J (1980) 1.94
Why does Australia have no national drug policy? Med J Aust (1992) 1.92
Sample size for short-term trials of antihypertensive drugs. Br J Clin Pharmacol (1982) 1.91
The mll-AF9 gene fusion in mice controls myeloproliferation and specifies acute myeloid leukaemogenesis. EMBO J (1999) 1.88
Cloning and expression of cyclosporin A- and FK506-sensitive nuclear factor of activated T-cells: NF45 and NF90. J Biol Chem (1994) 1.85
CD45-null transgenic mice reveal a positive regulatory role for CD45 in early thymocyte development, in the selection of CD4+CD8+ thymocytes, and B cell maturation. J Exp Med (1996) 1.83
Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multidrug resistant lung cancer cell lines. Cancer Res (1993) 1.81
Designing new treatment strategies in vital pulp therapy. J Dent (2000) 1.80
Natural infection with influenza A (H3N2). The development, persistance and effect of antibodies to the surface antigens. J Hyg (Lond) (1976) 1.77
Specialist phototrophs, lithotrophs, and methylotrophs: a unity among a diversity of procaryotes? Bacteriol Rev (1977) 1.72
Binding of anilide-type local anesthetics in human plasma. I. Relationships between binding, physicochemical properties, and anesthetic activity. Anesthesiology (1970) 1.71
The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes. Br J Clin Pharmacol (1992) 1.71
The spectrum of skin disorders in abdominal stoma patients. Br J Dermatol (2000) 1.69
Plasma concentrations of local anaesthetics after interscalene brachial plexus block. Br J Anaesth (1977) 1.66
Assessment of ocular transduction using single-stranded and self-complementary recombinant adeno-associated virus serotype 2/8. Gene Ther (2007) 1.66
Metoprolol metabolism and debrisoquine oxidation polymorphism--population and family studies. Br J Clin Pharmacol (1985) 1.64
The bio-availability of fluoride from black tea. J Dent (2001) 1.62
The use of a radial haemolysis test for neuraminidase antibodies in the diagnosis of influenza A infection. J Hyg (Lond) (1983) 1.60
Thiosulphate metabolism and rhodanese in Chromatium sp. strain D. J Gen Microbiol (1966) 1.60
Professional attitudes to cardiopulmonary resuscitation in departments of geriatric and general medicine. J R Coll Physicians Lond (1993) 1.59
MRP3, an organic anion transporter able to transport anti-cancer drugs. Proc Natl Acad Sci U S A (1999) 1.59
Restoration of vision in RPE65-deficient Briard dogs using an AAV serotype 4 vector that specifically targets the retinal pigmented epithelium. Gene Ther (2006) 1.59
Evidence-based medicine in toxicology: where is the evidence? Lancet (1996) 1.58
A six-year evaluation of methadone prescribing practices at a substance misuse treatment centre in the UK. J Clin Pharm Ther (2006) 1.58
The microbiology of the acute dental abscess. J Med Microbiol (2009) 1.55
Comparison of two long-acting preparations of metoprolol with conventional metoprolol and atenolol in healthy men during chronic dosing. Br J Clin Pharmacol (1982) 1.55
Open access echocardiography: a prospective audit of referral patterns from primary care. Int J Clin Pract (2003) 1.54
Defective metabolism of metoprolol in poor hydroxylators of debrisoquine. Br J Clin Pharmacol (1982) 1.52
Lack of effect of atenolol on antipyrine clearance. Br J Clin Pharmacol (1982) 1.51
Lymph node retrieval and assessment in stage II colorectal cancer: a population-based study. Ann Surg Oncol (2003) 1.51
Barefoot doctors and the medical pyramid. Br Med J (1974) 1.49
A study of visual and blood contamination on reprocessed endodontic files from general dental practice. Br Dent J (2005) 1.49
Estrogen acutely abolishes abnormal cold-induced coronary constriction in men. Chest (1998) 1.49
Long-term preservation of retinal function in the RCS rat model of retinitis pigmentosa following lentivirus-mediated gene therapy. Gene Ther (2005) 1.48
Gene therapy with a promoter targeting both rods and cones rescues retinal degeneration caused by AIPL1 mutations. Gene Ther (2009) 1.48
Renal action, therapeutic use, and pharmacokinetics of the diuretic bumetanide. Clin Pharmacol Ther (1974) 1.47
Transient hemiparetic attacks due to unrecognised nocturnal hypoglycaemia. Br Med J (Clin Res Ed) (1981) 1.47
Clinical pharmacokinetics of local anaesthetics. Clin Pharmacokinet (1979) 1.47
Stem cells and the dental pulp: potential roles in dentine regeneration and repair. Oral Dis (2007) 1.46
Gene replacement therapy in the retinal degeneration slow (rds) mouse: the effect on retinal degeneration following partial transduction of the retina. Hum Mol Genet (2001) 1.46
The Hox11 gene is essential for cell survival during spleen development. Development (1995) 1.45
Pre-sterilisation cleaning of re-usable instruments in general dental practice. Br Dent J (2007) 1.45
Inhibitory effect of the reversal agents V-104, GF120918 and Pluronic L61 on MDR1 Pgp-, MRP1- and MRP2-mediated transport. Br J Cancer (2000) 1.43
Characterization and dynamics of O-linked glycosylation of human cytokeratin 8 and 18. J Biol Chem (1992) 1.43
Effects of amiloride on active sodium transport by the isolated frog skin: evidence concerning site of action. Br J Pharmacol (1970) 1.42
Risk factors for variant Creutzfeldt-Jakob disease in dental practice: a case-control study. Br Dent J (2012) 1.42
Caffeine urinary metabolite ratios as markers of enzyme activity: a theoretical assessment. Pharmacogenetics (1996) 1.41